Obviousness-type double patenting spurs need for careful counsel Pharmaceutical companies in the US tell Managing IP that it’s important to have considered and knowledgeable law firm partners when tackling this increasingly challenging legal doctrine By Patrick Wingrove March 27 2020
Managing IP Americas Awards 2020: winners revealed Find out who won in a host of categories in the US and across the Americas By Chris Adams & Ed Conlon March 26 2020
Divisional filings at USPTO and EPO ‘legal but evil’ Generics companies say innovators abuse divisional filing systems to prolong patent life and frustrate their competitors’ freedom to launch By Charlotte Kilpatrick March 26 2020
Siemens Americas chief puts trade secrets and patent eligibility at top of agenda In an exclusive interview, chief IP counsel Daniel Staudt says his company’s IP function has been mostly unaffected by COVID-19 and that external counsel must act as business partners By Patrick Wingrove March 25 2020
IP judges report: 10 interviews from the world’s key jurisdictions Managing IP has compiled interviews conducted in the past 12 months, giving insight on what makes judges tick and what this means for you By Ed Conlon March 24 2020
East v west: how to pick your patent battles in Texas In-house and private practice counsel say the Western District of Texas’s promises of efficiency are alluring, but that the breadth of case law in the Eastern District makes it more predictable By Patrick Wingrove March 23 2020
Managing IP Americas Awards 2020 The winners of the Managing IP Americas Awards 2020 will be revealed on our website on March 26 at 10am EST (New York) By Kingsley Egbuonu March 23 2020
Why the Western District of Texas could be America’s next top forum Managing IP asks in-house and private practice counsel why an increasing number of patent litigators are filing in Alan Albright’s court rather than in the Eastern District of Texas By Patrick Wingrove March 17 2020
COVID-19: Patents are not adequate incentives for vaccine research Pharma in-house attorneys and private counsel explore different reward schemes for vaccine research including vouchers and government prize money By Charlotte Kilpatrick March 17 2020
